Derivation Web

v0.1 · api
source · application/json

source_9cfd0e8dbcdd4c01

sha256 21f20eda17ad896f3edf599123005fcada52cfa4a2836871882afd23f39603c8

by researka:v2 · 2026-06-01 15:36:05.849800+04:00

{"publication_id": "e2acb093-79b1-4513-8106-e291ece5791d", "traces": [{"candidate_sources": [{"doi": "10.3390/nu16050679", "study": "Preventive Vitamin D Supplementation and Risk for COVID-19 Infection: A Systematic Review and Meta-Analysis", "url": null}, {"doi": "10.1002/14651858.cd011564.pub3", "study": "Vitamin D supplementation for chronic liver diseases in adults", "url": null}, {"doi": "10.3390/ijms26052153", "study": "Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications—A Narrative Review", "url": null}, {"doi": "10.3390/nu15020334", "study": "Role of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseases", "url": null}, {"doi": "10.3390/nu13030717", "study": "Vitamin D and Lung Outcomes in Elderly COVID-19 Patients", "url": null}], "claim": "The cited receipts show an apparent collision between a positive direct signal in general population (analytical studies) (vitamin D supplementation has a protective effect against the incidence of COVID-19 in analytical studies (OR = 0.592, 95% IC 0.476-0.736)) and an opposing endpoint in adults with chronic liver diseases (We are very uncertain regarding the effect of vitamin D versus placebo or no intervention on all-cause mortality (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.51 to", "claim_id": "claim_1"}, {"candidate_sources": [{"doi": "10.3390/nu16050679", "study": "Preventive Vitamin D Supplementation and Risk for COVID-19 Infection: A Systematic Review and Meta-Analysis", "url": null}, {"doi": "10.1002/14651858.cd011564.pub3", "study": "Vitamin D supplementation for chronic liver diseases in adults", "url": null}, {"doi": "10.3390/ijms26052153", "study": "Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications—A Narrative Review", "url": null}, {"doi": "10.3390/nu15020334", "study": "Role of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseases", "url": null}, {"doi": "10.3390/nu13030717", "study": "Vitamin D and Lung Outcomes in Elderly COVID-19 Patients", "url": null}], "claim": "Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.", "claim_id": "claim_2"}, {"candidate_sources": [{"doi": "10.3390/nu16050679", "study": "Preventive Vitamin D Supplementation and Risk for COVID-19 Infection: A Systematic Review and Meta-Analysis", "url": null}, {"doi": "10.1002/14651858.cd011564.pub3", "study": "Vitamin D supplementation for chronic liver diseases in adults", "url": null}, {"doi": "10.3390/ijms26052153", "study": "Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications—A Narrative Review", "url": null}, {"doi": "10.3390/nu15020334", "study": "Role of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseases", "url": null}, {"doi": "10.3390/nu13030717", "study": "Vitamin D and Lung Outcomes in Elderly COVID-19 Patients", "url": null}], "claim": "`fact_id=77927` (`A_core`) — We are very uncertain regarding the effect of vitamin D versus placebo or no intervention on all-cause mortality (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.51 to 1.45; 27 trials; 1979 participants). doi=10.1002/14651858.cd011564.pub3", "claim_id": "claim_3"}, {"candidate_sources": [{"doi": "10.3390/nu16050679", "study": "Preventive Vitamin D Supplementation and Risk for COVID-19 Infection: A Systematic Review and Meta-Analysis", "url": null}, {"doi": "10.1002/14651858.cd011564.pub3", "study": "Vitamin D supplementation for chronic liver diseases in adults", "url": null}, {"doi": "10.3390/ijms26052153", "study": "Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications—A Narrative Review", "url": null}, {"doi": "10.3390/nu15020334", "study": "Role of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseases", "url": null}, {"doi": "10.3390/nu13030717", "study": "Vitamin D and Lung Outcomes in Elderly COVID-19 Patients", "url": null}], "claim": "_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._", "claim_id": "claim_4"}, {"candidate_sources": [{"doi": "10.3390/nu16050679", "study": "Preventive Vitamin D Supplementation and Risk for COVID-19 Infection: A Systematic Review and Meta-Analysis", "url": null}, {"doi": "10.1002/14651858.cd011564.pub3", "study": "Vitamin D supplementation for chronic liver diseases in adults", "url": null}, {"doi": "10.3390/ijms26052153", "study": "Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications—A Narrative Review", "url": null}, {"doi": "10.3390/nu15020334", "study": "Role of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseases", "url": null}, {"doi": "10.3390/nu13030717", "study": "Vitamin D and Lung Outcomes in Elderly COVID-19 Patients", "url": null}], "claim": "`fact_id=77927` (`A_core`) — We are very uncertain regarding the effect of vitamin D versus placebo or no intervention on all-cause mortality (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.51 to 1.45; 27 trials; 1979 participants). Source: Vitamin D supplementation for chronic liver diseases in adults", "claim_id": "claim_5"}, {"candidate_sources": [{"doi": "10.3390/nu16050679", "study": "Preventive Vitamin D Supplementation and Risk for COVID-19 Infection: A Systematic Review and Meta-Analysis", "url": null}, {"doi": "10.1002/14651858.cd011564.pub3", "study": "Vitamin D supplementation for chronic liver diseases in adults", "url": null}, {"doi": "10.3390/ijms26052153", "study": "Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications—A Narrative Review", "url": null}, {"doi": "10.3390/nu15020334", "study": "Role of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseases", "url": null}, {"doi": "10.3390/nu13030717", "study": "Vitamin D and Lung Outcomes in Elderly COVID-19 Patients", "url": null}], "claim": "`fact_id=178491` (`B_context`) — supplementation with 2 000 IU/d of vitamin D did not reduce the risk of total or hip fractures Source: The Effects of Vitamin D Supplementation on Musculoskeletal Health: The VITAL and DO-Health Trials", "claim_id": "claim_6"}]}
metadata
{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "e2acb093-79b1-4513-8106-e291ece5791d",
  "researka_submission_id": "258a2df7-c118-43c3-b38d-35a7e6f66934",
  "sidecar_name": "citation_traces.json",
  "sidecar_url": "https://api.researka.org/publications/e2acb093-79b1-4513-8106-e291ece5791d/sidecars/citation_traces.json"
}

view full chain →